These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2486235)

  • 1. [Synthesis of N-(4-carbethoxy-4-substituted butyryl)-N-substituted glycines].
    Chen YM; Cai CY; Gong KS
    Yao Xue Xue Bao; 1989; 24(12):887-94. PubMed ID: 2486235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis of N-(4-carbomethoxy-4-phthalimidobutanoyl)-N-substituted glycines, proline and pyroglutamic acid].
    Lin WQ; Cai CY; Gong KS; Wu Y; Long Z; Luo XX; Yang L; Li JF; Yao XJ
    Yao Xue Xue Bao; 1994; 29(5):346-54. PubMed ID: 7976352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis of N-(4-substituted amino-4-oxobutyryl)-N-substituted glycines].
    Wu Y; Cai CY; Gong KS
    Yao Xue Xue Bao; 1992; 27(9):717-20. PubMed ID: 1293947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and angiotension converting enzyme inhibitory activity of L-lysyl-N-substituted glycine derivatives.
    Saito S; Matsui S; Fukushima S; Watanabe M; Waga T; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
    Arzneimittelforschung; 1989 Dec; 39(12):1558-61. PubMed ID: 2560371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis of N-(2-mercaptobenzoyl)-N-(alkyl/aryl)-glycines and corresponding disulfides].
    Chen PL; Yang ZX; Peng SX
    Yao Xue Xue Bao; 1987 Sep; 22(9):662-70. PubMed ID: 3445757
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synthesis of N-(2-mercaptopyridyl-3-formyl)-N-alkyl glycine and the corresponding disulfides].
    Luo YL; Yang ZX; Peng SX
    Yao Xue Xue Bao; 1990; 25(5):374-8. PubMed ID: 2284959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors.
    Ciabatti R; Tarzia G; Battaglia F; Barone D; Baldoli E
    Farmaco Sci; 1988 Dec; 43(12):989-1003. PubMed ID: 2854788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 2-substituted-N-carboxymethyl-1,5-benzothiazepin-4-ones and -1,4-benzothiazin-3-ones and their evaluation as angiotensin converting enzyme inhibitors.
    Trapani G; Latrofa A; Franco M; Liso G
    Farmaco; 1995 Feb; 50(2):107-12. PubMed ID: 7766274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis of N,N-alkylene-bis-(substituted-phenol)glycine for removal of radio-actinides in rats].
    Sun MZ; Zhu PE; Tang C; Chen AF; Shen BY
    Yao Xue Xue Bao; 1990; 25(7):505-8. PubMed ID: 2085126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic effects of a novel dihydrobenzofuran analogue and enalapril on blood pressure and plasma and tissue angiotensin converting enzyme activity in the sodium deficient normotensive rat.
    Longman SD; Howlett DR
    Arzneimittelforschung; 1988 May; 38(5):678-82. PubMed ID: 2843192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.
    Fournie-Zaluski MC; Coric P; Thery V; Gonzalez W; Meudal H; Turcaud S; Michel JB; Roques BP
    J Med Chem; 1996 Jun; 39(13):2594-608. PubMed ID: 8691458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical and physiological activity of new peptide inhibitors of angiotensin-converting enzyme].
    Gomazkov OA; Pozdnev VF; Kalinina EV; Komissarova NV; Medvedeva NA; Nesterova MA; Petriĭ OP
    Biull Eksp Biol Med; 1996 Sep; 122(9):279-81. PubMed ID: 8974479
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
    Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
    J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effect of an angiotensin converting enzyme inhibitory peptide from enzyme modified cheese.
    Tonouchi H; Suzuki M; Uchida M; Oda M
    J Dairy Res; 2008 Aug; 75(3):284-90. PubMed ID: 18620614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and angiotensin converting enzyme-inhibitory activity of N-[(1S)-1-carboxy-5-(4-piperidyl)pentyl]-L-alanine derivatives.
    Kori M; Itoh K; Inada Y; Katoh T; Sumino Y; Nishikawa K; Sugihara H
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):580-5. PubMed ID: 8004703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y; Franco-Saenz R; Mulrow PJ
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
    Wilkes BM
    J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.